Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: | Avallon Paracetamol For Children 1 to 5 Years |
Active Ingredient: | Paracetamol 24mg/mL |
Dosage Form: | Oral suspension |
New Zealand Sponsor: | Noumed Pharmaceuticals Limited |
Manufacturer: | Gracure Pharmaceuticals Limited, Bhiwadi, India |
Note: This consent is given subject to the following condition:
- The product will only be supplied to meet an emergency PHARMAC tender and will not be sold in other circumstances until full consent is obtained.
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 29th day of August 2022.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).